Agios Pharmaceuticals (AGIO) Inventory Average (2018 - 2026)

Agios Pharmaceuticals' Inventory Average history runs 8 years deep, the most recent figure standing at $34.0 million for Q1 2026.

• Quarterly Inventory Average rose 18.85% year-over-year to $34.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.0 million (up 18.85% YoY) and the FY2025 annual result came in at $30.3 million, up 29.65% from the prior year.
• Inventory Average was $34.0 million for Q1 2026 at Agios Pharmaceuticals, up from $32.5 million in the prior quarter.
• Across five years, Inventory Average topped out at $34.0 million in Q1 2026 and bottomed at $3.3 million in Q2 2022.
• A 5-year average of $20.4 million and a median of $22.3 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average soared 313.22% — and 2026, when it rose 18.85%.
• Agios Pharmaceuticals' Inventory Average stood at $6.8 million in 2022, then jumped by 165.95% to $18.2 million in 2023, then soared by 48.68% to $27.0 million in 2024, then climbed by 20.19% to $32.5 million in 2025, then increased by 4.7% to $34.0 million in 2026.
• Business Quant data shows AGIO's Inventory Average at $34.0 million in Q1 2026, $32.5 million in Q4 2025, and $31.4 million in Q3 2025.